pindolol has been researched along with Malabsorption Syndromes in 2 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Malabsorption Syndromes: General term for a group of MALNUTRITION syndromes caused by failure of normal INTESTINAL ABSORPTION of nutrients.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pindolol kinetics and bioavailability were studied after a single dose (oral 5 mg; intravenous 3 mg) in nine patients with malabsorption (two with villous atrophies, seven with short bowel syndromes) and in six healthy volunteers." | 5.27 | Study of the bioavailability of pindolol in malabsorption syndromes. ( Aubry, JP; Cheymol, A; Cheymol, G; Evard, D; Le Quintrec, Y, 1984) |
| " To investigate pindolol absorption, a drug particularly well absorbed and with low hepatic extraction, plasma concentrations and 54-h urinary excretion (after both oral and intravenous dose) were studied in 6 healthy volunteers and 13 patients with intestinal malabsorption (coeliac disease 5 cases, short bowel syndrome 8 cases) after an overnight fasting." | 5.27 | [Evaluation of pindolol absorption in malabsorption syndromes]. ( Aubry, JP; Cheymol, A; Cheymol, G; Evard, D; Le Quintrec, Y, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evard, D | 2 |
| Aubry, JP | 2 |
| Le Quintrec, Y | 2 |
| Cheymol, G | 2 |
| Cheymol, A | 2 |
2 other studies available for pindolol and Malabsorption Syndromes
| Article | Year |
|---|---|
Study of the bioavailability of pindolol in malabsorption syndromes.
Topics: Administration, Oral; Adult; Biological Availability; Female; Humans; Injections, Intravenous; Intes | 1984 |
[Evaluation of pindolol absorption in malabsorption syndromes].
Topics: Administration, Oral; Adult; Female; Humans; Injections, Intravenous; Intestinal Absorption; Kinetic | 1983 |